Cell Lysis/Cell Fractionation Market

Thermo Fisher Scientific (US) and Merck (Germany) are the Major Players in the Cell Lysis/Cell Fractionation Market

The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2020, at a CAGR 7.2% from 2021 to 2026. The growth of this market is driven by increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicines

The cell lysis market is highly consolidated and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), Agilent Technologies Inc. (US), NZYTech Lda (Portugal), Labfreez Instruments Group Co., Limited (China), G-Biosciences (US), Covaris (US), Claremont BioSolutions LLC (US), Microfluidics International Corporation (US), Parr Instrument Company (US), BioVision Inc.(US), and Norgen Biotek (Canada).

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher Scientifc (US) held the leading position in the cell lysis market in 2020. Thermo Fisher offers an exhaustive product portfolio consisting of various cell lysis products, such as reagents, kits, and media. The company believes in both organic and inorganic growth for enhancing its market position such collaboration, acquisition and expansion.  For instance, in 2020, Thermo Fisher Scientific entered collaboration with Northeastern University To advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in personalized medicine, monoclonal antibodies, and gene and cell therapies. Furthermore, the company is innovation-centric and invests heavily in R&D to maintain its market share..

Merck (Germany)

Merck (Germany) accounted for the second-largest share of the global cell lysis market in 2020. The company provides its radiation dowing to its robust portfolio of cell lysis products and efforts to develop innovative products by investing in R&D. To sustain its leading position in the cell lysis market, the company pursues organic and inorganic strategies such as expansion. For instance, in 2020, the company expanded Life Science production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire, US

Related Reports:

Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 4209
RI Published ON
3/17/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Lysis/Cell Fractionation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved